Clinical Trial: A Study to Compare PK/PD Characteristics and Safety Profiles Between AD-120 and AD-120A

U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT06916130) titled 'A Study to Compare PK/PD Characteristics and Safety Profiles Between AD-120 and AD-120A' on March 25.

Brief Summary: Primary endpoint of this study is to evaluate the pharmacokinetic and pharmacodynamic characteristics of AD-120 in healthy subjects.

Study Start Date: April 21

Study Type: INTERVENTIONAL

Condition: Gastroesophageal Reflux Disease (GERD)

Intervention: DRUG: AD-120A

Administered before the breakfast during 7 days, Oral, Tablet

DRUG: AD-120

Administered before the breakfast during 7 days, Oral, Tablet

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Addpharma Inc.

Disclaimer: Curated by HT Syndication....